Know Cancer

or
forgot password

Detection of Plasma DNA by Allelotyping in Non Small Cell and Small Cell Lung Cancer Patients. Evolution During Treatment and Follow-up.


N/A
18 Years
N/A
Not Enrolling
Both
Non-Small Cell Lung Carcinoma, Small Cell Lung Cancer

Thank you

Trial Information

Detection of Plasma DNA by Allelotyping in Non Small Cell and Small Cell Lung Cancer Patients. Evolution During Treatment and Follow-up.


Inclusion Criteria:



- Presence of lung tumor to use fiberoscopy or surgical intervention for diagnosis.

- No lung instability.

- Individuals give all informed consent

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Screening

Principal Investigator

Michèle BEAU-FALLER, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Service de Pneumologie, Hôpital de Hautepierre

Authority:

France: Ministry of Health

Study ID:

2731

NCT ID:

NCT00213798

Start Date:

December 2003

Completion Date:

August 2011

Related Keywords:

  • Non-Small Cell Lung Carcinoma
  • Small Cell Lung Cancer
  • Lung cancer
  • plasma DNA
  • allelotyping
  • follow-up
  • Prospective Study
  • Non-Small Cell Lung Cancer
  • Small Cell Lung Cancer
  • Carcinoma
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms
  • Small Cell Lung Carcinoma

Name

Location